Side by side
Compare companies
Line up to six companies across valuation, growth, profitability, leverage, ownership and technicals. Best and worst per row are highlighted.
| Metric | SUNPHARMA | DIVISLAB | TORNTPHARM | APOLLOHOSP | ZYDUSLIFE |
|---|---|---|---|---|---|
| Size & Price | |||||
| Market capitalisation | ₹4,32,240 Cr | ₹2,45,561 Cr | ₹1,61,325 Cr | ₹1,16,960 Cr | ₹1,14,284 Cr |
| Enterprise value | ₹4,36,322 Cr | ₹2,45,561 Cr | ₹1,76,123 Cr | ₹1,22,618 Cr | ₹1,26,053 Cr |
| Revenue (TTM) | ₹59,911 Cr | ₹11,230 Cr | ₹15,723 Cr | ₹26,430 Cr | ₹28,592 Cr |
| EBITDA (TTM) | ₹17,847 Cr | ₹3,967 Cr | ₹5,191 Cr | ₹4,010 Cr | ₹8,316 Cr |
| PAT (TTM) | ₹12,096 Cr | ₹2,925 Cr | ₹2,181 Cr | ₹2,090 Cr | ₹4,513 Cr |
| Current price | ₹1,801.00 | ₹9,249.00 | ₹4,767.30 | ₹8,133.50 | ₹1,145.70 |
| 1-day change | -0.86% | -0.46% | -0.68% | -0.39% | -1.4% |
| Avg volume (30d) | — | — | — | — | — |
| 52-week high | — | — | — | — | — |
| 52-week low | — | — | — | — | — |
| Distance from 52w high | — | — | — | — | — |
| Distance from 52w low | — | — | — | — | — |
| Valuation | |||||
| Price to earnings | 35.7× | 84.0× | 74.0× | 56.0× | 25.3× |
| Price to book | 5.2× | 14.6× | 19.2× | 12.3× | 4.3× |
| Price to sales | 7.2× | 21.9× | 10.3× | 4.4× | 4.0× |
| EV / EBITDA | 24.4× | 61.9× | 33.9× | 30.6× | 15.2× |
| Dividend yield | 0.89% | 0.65% | 0.92% | 0.37% | 1.05% |
| Earnings yield | 2.8% | 1.19% | 1.35% | 1.79% | 3.95% |
| PEG ratio | 3.36 | 6.94 | 3.66 | 1.68 | 0.68 |
| Book value / share | ₹348.3 | ₹632.5 | ₹248.2 | ₹659.3 | ₹269.5 |
| EPS (TTM) | ₹50.4 | ₹110.4 | ₹64.5 | ₹145.3 | ₹44.9 |
| Growth | |||||
| Sales growth (1y) | 11.2% | 12.8% | 21.4% | 15.8% | 16.8% |
| Sales growth (3y CAGR) | 10% | 10.8% | 13.3% | 14.9% | 16.3% |
| Sales growth (5y CAGR) | 11.8% | 8.7% | 11.8% | 19% | 12.4% |
| Profit growth (1y) | 5% | 17.2% | 13.2% | 34.3% | 3,326.2% |
| Profit growth (3y CAGR) | 10.6% | 12.1% | 20.2% | 33.3% | 37% |
| Profit growth (5y CAGR) | 31.6% | 5.3% | 11.6% | 66.8% | 18.8% |
| Qtr sales growth (YoY) | 10.5% | 27.8% | 54.8% | 20.6% | 22% |
| Qtr profit growth (YoY) | 26.5% | 65.5% | 3.3% | 38.4% | -34.9% |
| Profitability | |||||
| Operating margin | 30.3% | 32.6% | 32.6% | 14.9% | 31.2% |
| Net margin | 19.7% | 24.3% | 15.3% | 7.9% | 18.9% |
| Return on equity | 14.7% | 16.2% | 27.1% | 21.9% | 19.7% |
| Return on capital employed | 20.9% | 20.8% | 14.5% | 19.4% | 23.4% |
| Return on assets | 10.6% | 12.8% | 4.8% | 9% | 9.8% |
| ROE (3y avg) | 15.6% | 14.6% | 26.3% | 18.2% | 7% |
| ROCE (3y avg) | 19.9% | 18.7% | 23.8% | 17.5% | 23.4% |
| Leverage & Quality | |||||
| Debt to equity | 0.05 | 0 | 1.76 | 0.6 | 0.43 |
| Interest coverage | 49.5× | 151.5× | 8.7× | 6.9× | 17.3× |
| Current ratio | 2.82 | 5.43 | 1.13 | 1.06 | 1.27 |
| Working capital days | 228 | 348 | 163 | 3 | 212 |
| Ownership | |||||
| Promoter holding | 54.5% | 51.9% | 68.3% | 28% | 75% |
| Promoter pledge | 0% | 0% | 0% | 0% | 0% |
| FII holding | 14.5% | 20.2% | 15.4% | 41.5% | 6.9% |
| DII holding | 22.1% | 19.3% | 9.7% | 23.7% | 11.3% |
| Public holding | 8.8% | 8.5% | 6.4% | 6.5% | 6.8% |
| Promoter holding change (1y) | 0% | -0.01% | 0% | -1.32% | 0.02% |
| Technical | |||||
| 50-day moving average | — | — | — | — | — |
| 200-day moving average | — | — | — | — | — |
| Price vs 50 DMA | — | — | — | — | — |
| Price vs 200 DMA | — | — | — | — | — |
| RSI (14) | — | — | — | — | — |
| Return (1m) | — | — | — | — | — |
| Return (3m) | — | — | — | — | — |
| Return (6m) | — | — | — | — | — |
| Return (1y) | — | — | — | — | — |
| Return (3y CAGR) | — | — | — | — | — |
| Relative strength (1y) | — | — | — | — | — |
| Volatility (1y) | — | — | — | — | — |
| Beta | — | — | — | — | — |
best in row weakest in rowRows without a better/worse direction aren't highlighted.